Schedule 13G ownership disclosure

Cumberland Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 230770109

Event date: 2017-05-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,083,469
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-17-000264
Form type
SC 13G
Filer
CUMBERLAND PHARMACEUTICALS INC
CIK
CIK 1087294
Filed
May 19, 2017
Reporting period
May 09, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub